News

Introducing a New Seasonal Flavor from Harvest Snaps!

Introducing a New Seasonal Flavor from Harvest Snaps!

Harvest Snaps Unveils a Seasonal Sensation

Calbee's Harvest Snaps is excited to announce the launch of a limited edition flavor that adds a festive twist to its popular snack offerings. Introducing the Jalapeño Pepper Jelly with Cream Cheese Baked Snacks, this new product combines sweet and savory notes with just a hint of heat, making it a great addition to any snack collection.

Flavor Profile and Nutritional Benefits

These new snacks are crafted with green peas as the primary ingredient, ensuring every bite is both delicious and nutritious. The carefully selected peas are milled whole in-house, which not only retains maximum nutritional benefits but also delivers 5g of plant protein and a healthy dose of fiber in each serving. Whether you're hosting a party or treating yourself during a snack craving, these baked snacks are sure to impress.

Perfect for Any Occasion

The Jalapeño Pepper Jelly with Cream Cheese Baked Snacks provides an unexpected twist on a traditional flavor duo. These intriguingly salty and sweet snacks aren't just for enjoyment; they're fantastic for gatherings, stuffing stockings, or simply munching right from the bag. Free of common allergens and certified gluten-free, they cater to various dietary needs, promoting guilt-free snacking.

The Inspiration Behind the Flavor

Maiko Shimano, the director of marketing at Calbee America, Inc., expressed the excitement about this new offering by stating, "This new, special edition puts a delightfully surprising twist on our core lineup. It showcases just how fun and tasty a veggie snack can be while maintaining Harvest Snaps' philosophy of delivering powerful, veggie-first nutrition. Snap up a bag while you can!" This enthusiasm illustrates the brand's commitment to innovation in the snack market.

About Calbee America, Inc.

With over 70 years of experience in the snack industry, Calbee has established itself as the top veggie-based snack brand for eight consecutive years. Their mission is to create delicious snacks from nutrient-dense vegetables, supporting healthy lifestyles. The Harvest Snaps line showcases how tasty and fun veggie snacks can be while maintaining nutritional integrity. For more information, visit their website or follow their social media.

Availability of New Flavor

The Jalapeño Pepper Jelly with Cream Cheese Baked Snacks are now available at select retailers and online. With an anticipated shelf life spanning several months, they'll be around to satisfy your cravings throughout the season. Be sure to grab a bag of these unique snacks before they disappear!

Frequently Asked Questions

What are the main ingredients in the new Jalapeño Pepper Jelly snacks?

The main ingredient is green peas, along with Jalapeño pepper jelly and cream cheese, creating a sweet and savory flavor profile.

Are these snacks gluten-free?

Yes, Harvest Snaps' new snacks are certified gluten-free and free from common allergens such as wheat, soy, and nuts.

Where can I purchase the new flavor?

The Jalapeño Pepper Jelly with Cream Cheese Baked Snacks can be found at select retailers and online at the Harvest Snaps website.

How many grams of protein do these snacks contain?

Each serving of these snacks contains 5g of plant protein, offering a nutritious snack option.

Is there a recommended way to enjoy these snacks?

They are great for serving at parties, stuffing in stockings, or simply enjoying straight out of the bag for a quick and delicious snack.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 20

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading